Patent Assignment
Reel/Frame 016290/0315
Assignment of Assignor's Interest
Recorded: 2005-07-21
Pages: 3
Assignor
SAVIENT PHARMACEUTICALS, INC.
Executed: 2005-06-21
Assignee
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
KIRYAT WEIZMANN, REHOVOT, 76326, ISRAEL
Covered Properties
(3)
High Molecular Weight Sodium Hyaluronate
Patent:
4,784,990 →
Application:
06/692,692 →
Method of Producing High Molecular Weight Sodium Hyaluronate by Fermentation of Streptococcus
Patent:
4,780,414 →
Application:
06/815,957 →
Syringe
Patent:
403,064 →
Application:
29/040,830 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Apr 15, 1985
From: NIMROD, ABRAHAM; GREENMAN, BENJAMIN; KANNER, DOV; LANDSBERG, MOSHE
To: BIO-TECHNOLOGY GENERAL CORPORATION,A CORP. OF DE.
Reel/Frame 004396/0399 →
Assignment of Assignors Interest.
Jul 25, 1988
From: BECK, YAFFA
To: BIO-TECHNOLOGY GENERAL CORP., 375 PARK AVENUE, SUITE 3303, NEW YORK, NEW YORK 10152, A CORP. OF DE
Reel/Frame 004917/0849 →
Security Interest
Oct 25, 1989
From: BIO-TECHNOLOGY GENERAL CORP., A CORP. OF DE
To: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
Reel/Frame 005208/0682 →
Assignment of Assignor's Interest
Sep 11, 1995
From: EINAV, YEHUDA; EYAL, DROR
To: BIO-TECHNOLOGY GENERAL CORP.
Reel/Frame 007646/0784 →
Change of Name
Jan 16, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014871/0808 →
Change of Name
Jun 21, 2004
From: BIO-TECHNOLOGY GENERAL CORP.
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 014754/0469 →
Release of Security Interest
Jul 1, 2005
From: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
To: SAVIENT PHARMACEUTICALS, INC. (FORMERLY KNOWN AS BIO-TECHNOLOGY GENERAL CORP.)
Reel/Frame 016460/0231 →
Release of Patent Collateral Assignment
Jul 1, 2005
From: CONTINENTAL STOCK TRANSFER AND TRUST COMPANY
To: SAVIENT PHARMACEUTICALS, INC. (FORMERLY KNOWN AS BIO-TECHNOLOGY GENERAL CORP.)
Reel/Frame 016460/0241 →